Economic Evaluations of Cancer Screening Tests in the US

This document is a systematic literature review (SLR) that evaluates the economic impact of cancer screening tests in the United States. It includes a comprehensive analysis of 73 studies published between 2008 and 2023, focusing on the cost-effectiveness of various screening methods for different types of cancer. The review outlines inclusion and exclusion criteria for the studies, detailing the populations assessed, the interventions employed, and the outcomes measured. It presents findings that indicate cancer screenings generally improve life expectancy and offer good economic value, particularly for higher-risk groups. The review categorizes the studies based on the type of cancer and the economic analysis performed, including cost-effectiveness and cost-utility analyses. Additionally, it discusses the methodologies used in the studies, such as budget impact models and cost-benefit analyses, providing a structured overview of the evidence supporting the economic evaluations of cancer screening tests.